Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Terui

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Pain and Symptom Management|January 8, 2017
Collusions Between Patients and Clinicians in End-of-Life Care: Why Clarity MattersFriedrich Stiefel, Kenji Nakamura, Takeshi Terui, et al.
Journal of Pain and Symptom Management|November 11, 2017
The Collusion Classification Grid: A Supervision and Research ToolFriedrich Stiefel, Kenji Nakamura, Takeshi Terui, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2014
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibodyToshimichi Ishihara, Michiyo Kanagawa, Junichi Koyama, et al.
The American Journal of Hospice & Palliative Care|October 18, 2013
A survey of patients who were referred to our palliative care division from other hospitals and appeared to have obvious indications for cancer chemotherapiesYasuo Hirayama, Takeshi Terui, Toshiro Kusakabe, et al.
International Journal of Clinical Oncology|January 5, 2019
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patientsSatoko Ito, Haruyuki Ito, Noriyuki Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]Hironobu Araki, Takuya Matsunaga, Kazuyuki Murase, et al.
Palliative & Supportive Care|November 5, 2013
Effectiveness of multidisciplinary team conference on decision-making surrounding the application of continuous deep sedation for terminally ill cancer patientsKazuhiko Koike, Takeshi Terui, Yuji Takahashi, et al.
Cancers|October 14, 2022
Genome-Wide Association Study Identifies Candidate Loci Associated with Opioid Analgesic Requirements in the Treatment of Cancer PainDaisuke Nishizawa, Takeshi Terui, Kunihiko Ishitani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib]Kazuyuki Murase, Takuya Matsunaga, Naoko Takeuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 18, 2004
[Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)]Kazuyuki Murase, Takuya Matsunaga, Rishu Takimoto, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Pain and Symptom Management|January 8, 2017
Collusions Between Patients and Clinicians in End-of-Life Care: Why Clarity MattersFriedrich Stiefel, Kenji Nakamura, Takeshi Terui, et al.
Journal of Pain and Symptom Management|November 11, 2017
The Collusion Classification Grid: A Supervision and Research ToolFriedrich Stiefel, Kenji Nakamura, Takeshi Terui, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2014
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibodyToshimichi Ishihara, Michiyo Kanagawa, Junichi Koyama, et al.
The American Journal of Hospice & Palliative Care|October 18, 2013
A survey of patients who were referred to our palliative care division from other hospitals and appeared to have obvious indications for cancer chemotherapiesYasuo Hirayama, Takeshi Terui, Toshiro Kusakabe, et al.
International Journal of Clinical Oncology|January 5, 2019
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patientsSatoko Ito, Haruyuki Ito, Noriyuki Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]Hironobu Araki, Takuya Matsunaga, Kazuyuki Murase, et al.
Palliative & Supportive Care|November 5, 2013
Effectiveness of multidisciplinary team conference on decision-making surrounding the application of continuous deep sedation for terminally ill cancer patientsKazuhiko Koike, Takeshi Terui, Yuji Takahashi, et al.
Cancers|October 14, 2022
Genome-Wide Association Study Identifies Candidate Loci Associated with Opioid Analgesic Requirements in the Treatment of Cancer PainDaisuke Nishizawa, Takeshi Terui, Kunihiko Ishitani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib]Kazuyuki Murase, Takuya Matsunaga, Naoko Takeuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 18, 2004
[Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)]Kazuyuki Murase, Takuya Matsunaga, Rishu Takimoto, et al.
Pageof 4